c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
MAIA
MAIA Biotechnology, Inc.
stock
NYSEAMERICAN
Market Open
Nov 16, 2026 11:01:30 AM EST
0.98
USD
-2.000%
(-0.02)
324,734
Pre-market
Nov 16, 2026 9:17:30 AM EST
1.00
USD
0.000%
(0.00)
After-hours
0.8600
Bid
1.1400
Ask
0.2800
Spread
Overview
Company
Exchanges
Shorts
News
News
MAIA News
1
/
1
Sep 23, 2026
Day breaks
Oct 8, 2026
06:30 AM EDT
Guide Architecture Expands Healthcare Design Platform with Acquisition of MAIA Consulting
·
Business Wire
Oct 7, 2026
08:15 AM EDT
MAIA Biotechnology Achieves Patient Enrollment Milestones in Ongoing Phase 2 and Pivotal Phase 3 Clinical Trials in Non-Small Cell Lung Cancer
·
GlobeNewswire Inc.
Oct 5, 2026
02:30 PM EDT
Compugen Ltd. (CGEN) Discusses COM701 in Ovarian Cancer, MAIA Trial Preview, and UNIGEN Platform Advancements Transcript
·
Seeking Alpha
Sep 23, 2026
09:17 AM EDT
MAIA Biotechnology Expands Pivotal Phase 3 THIO-104 Non-Small Cell Lung Cancer Trial into Spain and Portugal
·
GlobeNewswire Inc.
Sep 22, 2026
08:47 AM EDT
MAIA Biotechnology Reports Pivotal Phase 3 Clinical Trial Progress in Advanced Non-Small Cell Lung Cancer
·
GlobeNewswire Inc.
Sep 16, 2026
08:15 AM EDT
MAIA Biotechnology Doses First U.S. Patient in Ongoing Phase 2 Non-Small Cell Lung Cancer Clinical Trial
·
GlobeNewswire Inc.